The enrollment of subjects in a clinical trial of a domestic anxiolytic was completed ahead of schedule

The operational task of recruiting 200+ subjects for the study of the domestic anxiolytic was solved mainly by the St. Petersburg centers.

Pharmacotherapeutic group of the drug: anxiolytic agent. The drug has an anti-anxiety effect, manifested in the reduction or elimination of the mental, somatic and autonomic components of anxiety and fear, as well as irritability and disturbances of night sleep and cognitive functions caused by anxiety stress. At the same time, the drug has no sedative and muscle relaxant properties, it does not have a negative effect on the parameters of attention and memory, does not have a narcotic potential, drug dependence is not formed during its use and the "withdrawal" syndrome does not develop.